GREENLANE HOLDINGS INC - A (GNLN)

US3953303019 - Common Stock

0.5707  -0.04 (-6.64%)

After market: 0.5851 +0.01 (+2.52%)

Fundamental Rating

2

Overall GNLN gets a fundamental rating of 2 out of 10. We evaluated GNLN against 13 industry peers in the Distributors industry. GNLN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GNLN is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

GNLN had negative earnings in the past year.
In the past year GNLN has reported a negative cash flow from operations.
In the past 5 years GNLN always reported negative net income.
In the past 5 years GNLN always reported negative operating cash flow.

1.2 Ratios

GNLN has a worse Return On Assets (-91.70%) than 91.67% of its industry peers.
With a Return On Equity value of -288.10%, GNLN is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -91.7%
ROE -288.1%
ROIC N/A
ROA(3y)-33.93%
ROA(5y)-25.63%
ROE(3y)-78.32%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GNLN has a Gross Margin of 24.78%. This is comparable to the rest of the industry: GNLN outperforms 41.67% of its industry peers.
GNLN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for GNLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.75%
GM growth 5Y-4.81%

4

2. Health

2.1 Basic Checks

GNLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GNLN has been increased compared to 1 year ago.
The number of shares outstanding for GNLN has been reduced compared to 5 years ago.
Compared to 1 year ago, GNLN has a worse debt to assets ratio.

2.2 Solvency

GNLN has an Altman-Z score of -8.38. This is a bad value and indicates that GNLN is not financially healthy and even has some risk of bankruptcy.
GNLN has a worse Altman-Z score (-8.38) than 91.67% of its industry peers.
There is no outstanding debt for GNLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.38
ROIC/WACCN/A
WACC9.82%

2.3 Liquidity

A Current Ratio of 1.18 indicates that GNLN should not have too much problems paying its short term obligations.
GNLN has a Current ratio of 1.18. This is in the lower half of the industry: GNLN underperforms 75.00% of its industry peers.
A Quick Ratio of 0.47 indicates that GNLN may have some problems paying its short term obligations.
GNLN has a worse Quick ratio (0.47) than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 0.47

5

3. Growth

3.1 Past

GNLN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -345.30%.
GNLN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.81%.
The Revenue has been growing by 9.20% on average over the past years. This is quite good.
EPS 1Y (TTM)-345.3%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q98.33%
Revenue 1Y (TTM)-54.81%
Revenue growth 3Y-9.51%
Revenue growth 5Y9.2%
Revenue growth Q2Q-58.86%

3.2 Future

GNLN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.18% yearly.
GNLN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.36% yearly.
EPS Next Y90.64%
EPS Next 2Y40.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-34.57%
Revenue Next 2Y-12.07%
Revenue Next 3Y14.36%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

GNLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GNLN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

GNLN's earnings are expected to grow with 40.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.18%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GNLN!.
Industry RankSector Rank
Dividend Yield N/A

GREENLANE HOLDINGS INC - A

NASDAQ:GNLN (5/17/2024, 7:02:14 PM)

After market: 0.5851 +0.01 (+2.52%)

0.5707

-0.04 (-6.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.13M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -91.7%
ROE -288.1%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 24.78%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.18
Quick Ratio 0.47
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-345.3%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y90.64%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-54.81%
Revenue growth 3Y-9.51%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y